Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
- PMID: 12673720
- DOI: 10.1002/cncr.11266
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
Abstract
Background: Inactivation of the tumor suppressor gene PTEN/MMAC1/TEP1, located on chromosome 10q23, is a common event in advanced stages of diverse human malignancies. However, the prognostic role of PTEN expression in patients with hepatocellular carcinoma (HCC) has not been characterized.
Methods: One hundred five resected specimens were collected from patients with HCC. Expression levels of PTEN and p53 in clinical samples were analyzed by immunohistochemistry.
Results: Immunohistochemical analysis of 105 HCC tissue specimens revealed that decreased or absence of PTEN immunostaining was found in 43 specimens (40.9%). Reduced PTEN expression levels were correlated with increased tumor grade (P = 0.017), advanced disease stage (P = 0.016), and elevated serum alpha-fetoprotein (alphaFP) levels (P = 0.001). Kaplan-Meier analysis indicated that patients with reduced PTEN levels had shorter overall survival (P = 0.001) and higher recurrence rates (P = 0.0007) compared with patients who had intact PTEN expression. Examining p53 expression unveiled an inverse correlation between p53 overexpression and reduced PTEN expression in patients with HCC (P = 0.004). In addition, patients with p53 overexpression had shorter overall survival compared with patients who were without p53 overexpression (P = 0.0014). Univariate and multivariate analyses revealed that reduced PTEN expression was an independent prognostic factor for survival in patients with HCC.
Conclusions: The current study demonstrated that reduced PTEN expression levels are involved in the pathogenesis of HCC. Moreover, decreased PTEN expression was correlated with tumor progression, high alphaFP levels, p53 overexpression, and poor prognosis in patients with HCC.
Copyright 2003 American Cancer Society.
Similar articles
-
Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.Int J Cancer. 2002 Jul 10;100(2):152-7. doi: 10.1002/ijc.10458. Int J Cancer. 2002. PMID: 12115563
-
Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.Oncol Rep. 2007 Dec;18(6):1417-26. Oncol Rep. 2007. PMID: 17982625
-
Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast.Oncology. 2005;68(4-6):398-404. doi: 10.1159/000086981. Epub 2005 Jul 12. Oncology. 2005. PMID: 16020969
-
PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.Tumour Biol. 2017 Jun;39(6):1010428317705754. doi: 10.1177/1010428317705754. Tumour Biol. 2017. PMID: 28621226 Review.
-
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.Eur J Cancer. 2012 Oct;48(15):2328-38. doi: 10.1016/j.ejca.2012.03.001. Epub 2012 Mar 27. Eur J Cancer. 2012. PMID: 22459764 Free PMC article. Review.
Cited by
-
Human hepatocyte carcinogenesis (review).Int J Oncol. 2013 Apr;42(4):1133-8. doi: 10.3892/ijo.2013.1829. Epub 2013 Feb 19. Int J Oncol. 2013. PMID: 23426905 Free PMC article. Review.
-
Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice.Sci Rep. 2022 Sep 28;12(1):16206. doi: 10.1038/s41598-022-20296-3. Sci Rep. 2022. PMID: 36171333 Free PMC article.
-
Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.PLoS One. 2013;8(1):e54595. doi: 10.1371/journal.pone.0054595. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23355882 Free PMC article.
-
Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.Mol Cancer Ther. 2016 Nov;15(11):2553-2562. doi: 10.1158/1535-7163.MCT-15-0976. Epub 2016 Aug 5. Mol Cancer Ther. 2016. PMID: 27496136 Free PMC article.
-
Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.Gastroenterology. 2010 Dec;139(6):2170-82. doi: 10.1053/j.gastro.2010.09.002. Epub 2010 Sep 15. Gastroenterology. 2010. PMID: 20837017 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous